Ginger Graham is WBA Board Lead Independent Director. She has served on the WBA Board since 2010, and in October 2022, was named the Board’s Lead Independent Director. From November 2007 to December 2016, Ms. Graham advised numerous executives on building successful healthcare businesses as President and Chief Executive Officer of Two Trees Consulting, Inc. From 2003 to 2007, she was President and CEO of Amylin Pharmaceuticals, a biopharmaceutical company focused on first-in-class medicines for people with diabetes. Prior to that, Ms. Graham was Group Chairman, Office of the President for Guidant Corporation, a global leader in cardiology medical technology, which was recognized as one of Fortune’s “Best Companies to Work For in America” and one of IndustryWeek’s “100 Best Managed Companies in the World” during Ms. Graham’s tenure. Ms. Graham was on faculty at Harvard Business School from 2009 to 2012 and started her career at Eli Lilly and Company.
Ms. Graham served on the board of directors of Clovis Oncology, Inc. from 2013 to 2022. From 2018 to 2020, she served on the board of directors of Genomic Health, Inc. Ms. Graham sits on the advisory board for the Kellogg Center for Executive Women and is co-chair of the Center for Women’s Health Research at the University of Colorado. She has been recognized as one of PharmaVoice’s “100 Most Inspiring People” and one of World Pharmaceuticals’ “Top 40 Most Influential People” in the industry.